Detalhe da pesquisa
1.
Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial.
Lancet Infect Dis
; 23(4): 463-470, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460027